Table 2.
Distribution of NF-κB1 and NF-κBIA genotypes and allele in NSCLC patients and controls.
| Genotypes/alleles | Controls n (%) | Patients n (%) | O.R (95% CI) | P value |
|---|---|---|---|---|
| NF-κB1 | ||||
| II | 46 (46.47) | 35 (36.84) | Reference | |
| ID | 47 (47.47) | 44 (46.32) | 1.23 (0.67–2.25) | 0.500 |
| DD | 6 (6.06) | 16 (16.84) | 3.50 (1.24–9.87) | 0.014 |
| ID + DD | 53 (53.53) | 60 (63.16) | 1.49 (0.84–2.64) | 0.174 |
| I allele | 139 (70.2) | 114 (60) | Reference | |
| D allele | 59 (29.8) | 76 (40) | 1.57 (1.03–2.39) | 0.035 |
| NF-κBIA | ||||
| AA | 21 (21.21) | 17 (17.9) | Reference | |
| AG | 45 (45.46) | 45 (47.36) | 1.24 (0.58–2.65) | 0.587 |
| GG | 33 (33.33) | 33 (34.74) | 1.24 (0.55–2.75) | 0.605 |
| AG + GG | 78 (78.79) | 78 (82.1) | 1.24 (0.61–2.52) | 0.561 |
| A allele | 87 (43.94) | 79 (41.58) | Reference | |
| G allele | 111 (56.06) | 111 (58.42) | 1.10 (0.74–1.65) | 0.639 |
O.R: Odds ratio; CI: confidence interval.